Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: BRD 9876
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/500mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao
Related CAS#:
32703-82-5 93591-50-5
93591-46-9 1000781-10-1
13314-01-7 261711-90-4
610258-90-7 56322-35-1
77070-63-4 113769-02-1
1158522-08-7 940364-43-2
134104-43-1 844829-49-8
131615-57-1 6906-52-1
930439-75-1 1018584-77-4
1375289-11-4 849349-65-1

32703-82-5

32703-82-5 structure
32703-82-5 structure
  • Name: 6-tert-Butyl-2,3-naphthalenedicarbonitrile
  • Chemical Name: 6-tert-Butyl-2,3-naphthalenedicarbonitrile
  • CAS Number: 32703-82-5
  • Molecular Formula: C16H14N2
  • Molecular Weight: 234.29600
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage Kinesin
  • Create Date: 2018-06-23 18:56:41
  • Modify Date: 2024-01-09 14:46:30
  • BRD9876 is the “rigor” inhibitor that locks kinesin-5 (Eg5) in a state with enhanced microtubules (MTs) binding, leading to bundling and stabilization of MTs. BRD9876 interacts with the tyrosine 104 residue that is part of the α4-α6 allosteric binding pocket. BRD9876 specifically targets microtubule-bound Eg5 and selectively inhibits myeloma over CD34 cells. BRD9876 has the potential for multiple myeloma (MM) research[1][2][3][4].
Name 6-tert-Butyl-2,3-naphthalenedicarbonitrile
Synonyms 6-tert-butylnaphthalene-2,3-dicarbonitrile
MFCD00209558
Description BRD9876 is the “rigor” inhibitor that locks kinesin-5 (Eg5) in a state with enhanced microtubules (MTs) binding, leading to bundling and stabilization of MTs. BRD9876 interacts with the tyrosine 104 residue that is part of the α4-α6 allosteric binding pocket. BRD9876 specifically targets microtubule-bound Eg5 and selectively inhibits myeloma over CD34 cells. BRD9876 has the potential for multiple myeloma (MM) research[1][2][3][4].
Related Catalog
In Vitro BRD9876 (10 μM; 24 hours) reveales rapid arrest of cells at the G2/M phase starting as early as 2h of treatment in MM1S cells[1]. BRD9876 exhibits approximately 3-fold selectivity for MM1S myeloma cells (IC50=3.1 μM) over CD34+ derived hematopoietic cells (IC50=9.1 μM)[1]. BRD9876 (0.1, 1, 10, 100 uM) is able to overcome, in MM1S cells, stromal resistance of bone marrow stromal cells (BMSCs) from MM bone marrow aspirates but only minimal effects are observed with BRD9876 against primary MM cells[1]. BRD9876 is completely ineffective at inhibiting the basal ATPase activity of Eg5, in contrast to loop L5-binding monastrol or α4/α6-binding BI8 which shows greater activity against basal Eg5 ATPase activity[1]. Cell Cycle Analysis[1] Cell Line: MM1S cells and CD34 hematopoietic cells Concentration: 10 μM Incubation Time: 24 hours Result: Revealed rapid arrest of cells at the G2/M phase starting as early as 2h of treatment in MM1S cells. Showed markedly less G2/M arrest in CD34 hematopoietic cells.
References

[1]. Shrikanta Chattopadhyay, et al. Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors. Cell Rep. 2015 Feb 10;10(5):755-770.

[2]. Chieh-Ting Fang, et al. HSP70 regulates Eg5 distribution within the mitotic spindle and modulates the cytotoxicity of Eg5 inhibitors. Cell Death Dis. 2020 Sep 1;11(8):715.

[3]. Anke Maes, et al. The therapeutic potential of cell cycle targeting in multiple myeloma. Oncotarget. 2017 Jun 28;8(52):90501-90520.

[4]. Geng-Yuan Chen, et al. Eg5 Inhibitors Have Contrasting Effects on Microtubule Stability and Metaphase Spindle Integrity. ACS Chem Biol. 2017 Apr 21;12(4):1038-1046.
Density 1.11g/cm3
Boiling Point 429.7ºC at 760 mmHg
Melting Point 185-189ºC(lit.)
Molecular Formula C16H14N2
Molecular Weight 234.29600
Flash Point 206.6ºC
Exact Mass 234.11600
PSA 47.58000
LogP 3.88066
Index of Refraction 1.603
Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H302-H312-H332
Precautionary Statements P280
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xn: Harmful;
Risk Phrases 20/21/22
Safety Phrases 36
RIDADR NONH for all modes of transport
HS Code 2926909090
764-42-1 structure

764-42-1

183959-40-2 structure

183959-40-2

~44%

32703-82-5 structure

32703-82-5

Literature: Plater; Jeremiah; Bourhill Journal of the Chemical Society. Perkin Transactions 1, 2002 , vol. 2, # 1 p. 91 - 96
7397-06-0 structure

7397-06-0

~%

32703-82-5 structure

32703-82-5

Literature: Plater; Jeremiah; Bourhill Journal of the Chemical Society. Perkin Transactions 1, 2002 , vol. 2, # 1 p. 91 - 96
183959-40-2 structure

183959-40-2

764-42-1 structure

764-42-1

~%

32703-82-5 structure

32703-82-5

Literature: Kovshev,E.I. et al. Journal of Organic Chemistry USSR (English Translation), 1971 , vol. 7, p. 364 - 366 Zhurnal Organicheskoi Khimii, 1971 , vol. 7, # 2 p. 369 - 371
HS Code 2926909090
Summary HS:2926909090 other nitrile-function compounds VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Chemsrc provides CAS#:32703-82-5 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 32703-82-5 | Chemsrc address: https://www.chemsrc.com/en/baike/89184.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved